Waters (NYSE:WAT) posted its quarterly earnings results on Tuesday. The medical instruments supplier reported $2.16 earnings per share for the quarter, beating analysts’ consensus estimates of $1.93 by $0.23, MarketWatch Earnings reports. Waters had a net margin of 22.61% and a negative return on equity of 349.31%.
NYSE:WAT opened at $224.77 on Thursday. The firm has a market capitalization of $13.92 billion, a P/E ratio of 27.99, a P/E/G ratio of 8.79 and a beta of 0.97. The company has a fifty day moving average of $203.89 and a 200-day moving average of $200.17. Waters has a twelve month low of $154.39 and a twelve month high of $245.68.
In other Waters news, SVP Ian King sold 12,000 shares of the business’s stock in a transaction on Wednesday, August 19th. The shares were sold at an average price of $218.44, for a total transaction of $2,621,280.00. Following the completion of the sale, the senior vice president now owns 17,200 shares in the company, valued at approximately $3,757,168. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Christopher J. Oconnell sold 30,000 shares of the business’s stock in a transaction on Friday, July 31st. The shares were sold at an average price of $213.30, for a total transaction of $6,399,000.00. Following the sale, the chief executive officer now owns 57,595 shares of the company’s stock, valued at approximately $12,285,013.50. The disclosure for this sale can be found here. Insiders have sold a total of 66,381 shares of company stock valued at $14,280,481 in the last 90 days. 1.50% of the stock is currently owned by company insiders.
A number of equities research analysts have recently weighed in on WAT shares. Smith Barney Citigroup raised their price target on shares of Waters from $180.00 to $185.00 in a research note on Wednesday. Needham & Company LLC initiated coverage on shares of Waters in a research report on Tuesday, July 28th. They set a “sell” rating on the stock. Citigroup lifted their target price on shares of Waters from $150.00 to $180.00 and gave the stock a “sell” rating in a research report on Wednesday, July 29th. Stifel Nicolaus lifted their target price on shares of Waters from $220.00 to $230.00 and gave the stock a “hold” rating in a research report on Wednesday. Finally, Wells Fargo & Company lifted their target price on shares of Waters from $230.00 to $235.00 and gave the stock an “equal weight” rating in a research report on Wednesday. Four equities research analysts have rated the stock with a sell rating and eight have given a hold rating to the company’s stock. Waters presently has an average rating of “Hold” and a consensus price target of $197.60.
Waters Company Profile
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.
Read More: Pattern Day Trader – What is the PDT Rule?
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.